Back to top

Kyverna secures long-term miv-cel manufacturing partnership

Kyverna Therapeutics, Inc. ( ($KYTX) ) just unveiled an update. On July 23, 2026, Kyverna Therapeutics entered into a five-year clinical and commer...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: